Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
HOLY NAME MEDICAL CENTER, INC.
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Effectiveness of an Aerobic Exercise Program in Cancer Survivors.
Not Applicable
Not yet recruiting
Conditions
Aerobic Exercise
Subscribe
First Posted Date
2024-02-12
Last Posted Date
2024-02-12
Lead Sponsor
Holy Name Medical Center, Inc.
Target Recruit Count
15
Registration Number
NCT06254989
Subscribe
Intervention for Employed Women With Multiple Sclerosis
Not Applicable
Conditions
Multiple Sclerosis
Interventions
Behavioral: Neuropsychological testing intervention plus follow up
Subscribe
First Posted Date
2019-09-24
Last Posted Date
2021-02-18
Lead Sponsor
Holy Name Medical Center, Inc.
Target Recruit Count
89
Registration Number
NCT04100525
Subscribe
Effects of a Weight Based Training Program on MS Patients
Not Applicable
Conditions
Multiple Sclerosis
Interventions
Behavioral: Bodyweight training
Subscribe
First Posted Date
2019-06-28
Last Posted Date
2019-08-15
Lead Sponsor
Holy Name Medical Center, Inc.
Target Recruit Count
25
Registration Number
NCT04002492
Locations
🇺🇸
Holy Name Medical Center, Teaneck, New Jersey, United States
Subscribe
Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System
Completed
Conditions
Pancreatic Cancer
Interventions
Device: Nanoknife Irreversible Electroporation
Subscribe
First Posted Date
2018-08-03
Last Posted Date
2022-08-03
Lead Sponsor
Holy Name Medical Center, Inc.
Target Recruit Count
30
Registration Number
NCT03614910
Locations
🇺🇸
Holy Name Medical Center, Teaneck, New Jersey, United States
Subscribe
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Completed
Conditions
Stomach Cancer
Colorectal Cancer
Ovarian Cancer
Appendiceal Cancer
Primary Peritoneal Carcinoma
Uterine Cancer
Cervical Cancer
Fallopian Tube Cancer
Interventions
Device: HIPEC
Drug: CDDP 75
Drug: Mitomycin c
Drug: CDDP 50
Drug: Doxorubicin
Subscribe
First Posted Date
2018-07-27
Last Posted Date
2022-08-03
Lead Sponsor
Holy Name Medical Center, Inc.
Target Recruit Count
10
Registration Number
NCT03604653
Locations
🇺🇸
Holy Name Medical Center, Teaneck, New Jersey, United States
Subscribe
Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects
Phase 4
Conditions
Multiple Sclerosis
Interventions
Drug: Plegridy
Drug: Prednisone
Drug: Tylenol Pill
Subscribe
First Posted Date
2018-02-07
Last Posted Date
2019-08-15
Lead Sponsor
Holy Name Medical Center, Inc.
Target Recruit Count
50
Registration Number
NCT03424733
Locations
🇺🇸
Holy Name Medical Center, Teaneck, New Jersey, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy